Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy
Mohammed Salah Ayoup, Marwa M. Abu‐Serie, Hamida Abdel‐Hamid, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113475-113475
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Activators of Nrf2 to Counteract Neurodegenerative Diseases
Rosa Amoroso, Cristina Maccallini, Ilaria Bellezza
Antioxidants (2023) Vol. 12, Iss. 3, pp. 778-778
Open Access | Times Cited: 24
Design, synthesis and evaluation of antioxidant and anti-inflammatory activities of novel resveratrol derivatives as potential multifunctional drugs
Jiaxun Lu, Wei Wang, Qiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116148-116148
Closed Access | Times Cited: 6
Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents
Mohammed Salah Ayoup, Mohamed Reda Barakat, Hamida Abdel‐Hamid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 2080-2097
Closed Access | Times Cited: 6
Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation
Mohamed Reda Aouad, Meshal A. Almehmadi, Fawzia Faleh Albelwi, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105816-105816
Closed Access | Times Cited: 28
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles
Sergey V. Baykov, Антон А. Шетнев, Artem V. Semenov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5406-5406
Open Access | Times Cited: 14
Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential
Mohammed Salah Ayoup, Mariam M. ElShafey, Hamida Abdel‐Hamid, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115272-115272
Open Access | Times Cited: 13
Oxadiazole derivatives: Histone deacetylase inhibitors in anticancer therapy and drug discovery
Balaji Wamanrao Matore, Purusottam Banjare, Tanmoy Guria, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100058-100058
Open Access | Times Cited: 22
Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
Polycyclic aromatic compounds (2025), pp. 1-20
Closed Access
Unveiling the potential of xanthines, discovery of potential 7-benzyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione derivatives with antifibrotic activity for liver injury
Abdalla R. Mohamed, Hanan H. Georgey, Esraa A. Aidy, et al.
Bioorganic Chemistry (2025) Vol. 160, pp. 108441-108441
Closed Access
Synthesis and Antifungal Activity of 1,2,4-Oxadiazole Derivatives
Lili Yu, Kuan Yang, Lin Yao, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1851-1851
Open Access
Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury
Yaoqiang Lao, Yang Wang, Jianwen Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114315-114315
Closed Access | Times Cited: 18
Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease
Yuanyuan Wang, Baichen Xiong, Hongzhi Lin, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114806-114806
Closed Access | Times Cited: 18
Unveiling the therapeutic potential of 1,2,4-oxadiazole derivatives: An updated review
Hussam Elddin Nabeih Khasawneh, Ali Abdulrazzaq Abdulhussein Alrikabi, Amran M. AL-Erjan, et al.
Results in Chemistry (2025), pp. 102271-102271
Open Access
Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study
Ajay Mili, Subham Das, Krishnadas Nandakumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9193-9210
Closed Access | Times Cited: 13
New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives
Mihaela Stoyanova, Miglena Milusheva, Vera Gledacheva, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2321-2321
Open Access | Times Cited: 2
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome
Zhen Dai, Lu-yan An, Xiaoyi Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 5029-5043
Closed Access | Times Cited: 11
Thiol-promoted intermolecular cyclization to synthesize 1,2,4-oxadiazoles including tioxazafen under transition metal-free conditions
Congcong Yan, Min Zhang, Jiaxin Li, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 27, pp. 5616-5621
Closed Access | Times Cited: 4
1,3-Dipolar Cycloaddition Reaction of Nitrile Oxide to Thiocyanates: An Efficient and Eco-Friendly Synthesis of N-Aryl-2-((3-aryl-1,2,4-oxadiazol-5-yl)thio)acetamides
Vipin A. Nair, Vamshikrishna Y. Radhakrishna, Gopal L. Khatik
Synthesis (2024) Vol. 56, Iss. 20, pp. 3173-3180
Closed Access | Times Cited: 1
Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents
Mohamed N. Abd Al Moaty, El Sayed H. El Ashry, Laila F. Awad, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2422-2422
Open Access | Times Cited: 6
Discovery of novel benzimidazole acyclic C‐nucleoside DNA intercalators halting breast cancer growth
Mohamed N. Abd Al Moaty, Yeldez El Kilany, Laila F. Awad, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 3
An ultrasound assisted synthesis of spirooxindolo-1,2,4-oxadiazoles via [3+2] cycloaddition reaction and their anti-cancer activity
Madhu Kanchrana, Bhargava Sai Allaka, Gamidi Rama Krishna, et al.
ARKIVOC (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 2
Syntheses, characterizations, and Hirshfeld analysis of Ag(I) and Cu(II) complexes: A novel potent Ag(I)‐based oxadiazole anticancer agent
Mohammed Salah Ayoup, Mariam M. ElShafey, Hamida Abdel‐Hamid, et al.
Applied Organometallic Chemistry (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 2
Modulation of the KEAP1–NRF2 Pathway for the Treatment of Neurodegenerative Diseases: Rationale, Assay Methodologies, and Reference Compounds
José Clerigué, Jorge Pascual-Guerra, Rafael León, et al.
Neuromethods (2024), pp. 105-135
Closed Access
Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; Synthesis, evaluation, and molecular modelling studies
Mohammad Shahidul Islam, Refaah M. Al-Jassas, Abdullah Mohammed Al‐Majid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2937-2958
Closed Access
Page 1 - Next Page

Scroll to top